[go: up one dir, main page]

AU2957997A - 1,2,4-oxadiazoles as adhesion-receptor antagonists - Google Patents

1,2,4-oxadiazoles as adhesion-receptor antagonists

Info

Publication number
AU2957997A
AU2957997A AU29579/97A AU2957997A AU2957997A AU 2957997 A AU2957997 A AU 2957997A AU 29579/97 A AU29579/97 A AU 29579/97A AU 2957997 A AU2957997 A AU 2957997A AU 2957997 A AU2957997 A AU 2957997A
Authority
AU
Australia
Prior art keywords
oxadiazoles
adhesion
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29579/97A
Other languages
English (en)
Inventor
Sabine Bernotat-Danielowski
Joachim Gante
Horst Juraszyk
Guido Melzer
Hanns Wurziger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2957997A publication Critical patent/AU2957997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU29579/97A 1996-05-17 1997-05-20 1,2,4-oxadiazoles as adhesion-receptor antagonists Abandoned AU2957997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19620041 1996-05-17
DE19620041A DE19620041A1 (de) 1996-05-17 1996-05-17 Adhäsionsrezeptor-Antagonisten
PCT/EP1997/002555 WO1997044333A1 (de) 1996-05-17 1997-05-20 1,2,4-oxadiazole as adhäsionsrezeptor-antagonisten

Publications (1)

Publication Number Publication Date
AU2957997A true AU2957997A (en) 1997-12-09

Family

ID=7794651

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29579/97A Abandoned AU2957997A (en) 1996-05-17 1997-05-20 1,2,4-oxadiazoles as adhesion-receptor antagonists

Country Status (5)

Country Link
AR (1) AR007160A1 (es)
AU (1) AU2957997A (es)
DE (1) DE19620041A1 (es)
WO (1) WO1997044333A1 (es)
ZA (1) ZA974234B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729488B2 (en) * 1996-08-29 2001-02-01 Merck & Co., Inc. Compositions and methods for administering integrin receptor antagonists
AU742641B2 (en) 1998-01-28 2002-01-10 Shionogi & Co., Ltd. Novel tricyclic compound
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
JP2003504301A (ja) * 1998-04-01 2003-02-04 ブリストル−マイヤーズ スクイブ ファーマ カンパニー インテグリンアンタゴニスト
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
EP1100506A4 (en) * 1998-07-29 2002-06-26 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
ES2295150T3 (es) 2000-04-17 2008-04-16 Ucb Pharma, S.A. Derivados de enamina como moleculas de adhesion celular.
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6933304B2 (en) 2000-06-15 2005-08-23 Pharmacia Corporation Heteroarylalkanoic acids as integrin receptor antagonists
EP1301488A1 (en) 2000-07-07 2003-04-16 Celltech R&D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US7041685B2 (en) * 2001-06-08 2006-05-09 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003105771A2 (en) 2002-06-17 2003-12-24 Merck & Co., Inc. 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
AU2003297408A1 (en) 2002-12-20 2004-07-22 Pharmacia Corporation Thiazole compounds as integrin receptor antagonists derivatives
WO2004058254A1 (en) * 2002-12-20 2004-07-15 Pharmacia Corporation Heteroarylalkanoic acids as integrin receptor antagonists
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
ES2770035T3 (es) * 2003-04-11 2020-06-30 Ptc Therapeutics Inc Compuesto de ácido 1,2,4-oxadiazol benzoico y su uso para la supresión sin sentido y el tratamiento de enfermedades
WO2005058848A1 (en) 2003-12-17 2005-06-30 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
JP2008515992A (ja) 2004-10-13 2008-05-15 ピーティーシー セラピューティクス,インコーポレーテッド 体細胞変異に起因する疾患の阻止/治療用医薬を製造するための規定化合物の使用
US20080306124A1 (en) * 2005-06-08 2008-12-11 Rainer Albert Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
US20090325924A1 (en) * 2005-06-30 2009-12-31 Stuart Edward GPCR Agonists
WO2007117438A2 (en) 2006-03-30 2007-10-18 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
LT3357911T (lt) 2006-06-26 2022-08-10 Akebia Therapeutics Inc. Prolilo hidroksilazės inhibitoriai ir naudojimo būdai
JO2701B1 (en) 2006-12-21 2013-03-03 جلاكسو جروب ليميتد Vehicles
KR101273765B1 (ko) * 2008-06-24 2013-06-12 아이알엠 엘엘씨 G 단백질-커플링된 수용체를 조정하는 화합물 및 방법
NO2686520T3 (es) 2011-06-06 2018-03-17
JP2014522410A (ja) 2011-06-06 2014-09-04 アケビア セラピューティクス インコーポレイテッド がん治療のための方法として低酸素誘導因子−2αを安定化するための、化合物および組成物
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
RU2021125455A (ru) 2013-11-15 2021-10-05 Экебиа Терапьютикс, Инк. Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения
CA2942147C (en) 2014-03-06 2022-12-13 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
BR112017015852A2 (pt) 2015-01-23 2018-03-27 Akebia Therapeutics Inc forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1
TWI794725B (zh) 2015-04-01 2023-03-01 美商阿克比治療有限公司 用於治療貧血之組合物及方法
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
EP3790863A1 (en) 2018-05-09 2021-03-17 Akebia Therapeutics Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
GB202209228D0 (en) * 2022-06-23 2022-08-10 Univ Strathclyde Modified amino acids and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB935523A (en) * 1961-06-17 1963-08-28 Acraf New sulphamido-oxadiazoles
JPS51143669A (en) * 1975-06-06 1976-12-10 Takeda Chem Ind Ltd A process for preparing 1,2,4- oxadiazole derivatives
JPS52272A (en) * 1975-10-17 1977-01-05 Takeda Chem Ind Ltd Process for preparing 1,2,4-oxadiazole derivatives
US4135910A (en) * 1977-05-12 1979-01-23 Monsanto Company Oxadiazol-3-yl-benzoates as plant growth regulants
WO1994022846A1 (en) * 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents

Also Published As

Publication number Publication date
AR007160A1 (es) 1999-10-13
DE19620041A1 (de) 1998-01-29
WO1997044333A1 (de) 1997-11-27
ZA974234B (en) 1997-12-11

Similar Documents

Publication Publication Date Title
AU2957997A (en) 1,2,4-oxadiazoles as adhesion-receptor antagonists
AU1251697A (en) New substituted oxazolidinones
AU4073997A (en) 1,4-heterocyclic metallprotease inhibitors
AU1730497A (en) Fungicidal 1,2,4-oxadiazoles and analogues
HRP970454B1 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
AUPN772396A0 (en) The kouris centri-turbine generator
AU1642095A (en) 3,5-disubstituted tetrahydrofuran-2-ones
AU8441798A (en) Tricyclically substituted oxazolidinones
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
AU5530998A (en) Relatively stable (1,3-disubstitutedimidazol-2-ylidene)-type carbenes
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU7449998A (en) 2,3-dihydrobenzofuran derivatives
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU5692398A (en) Substituted 5-amino-1,3,4-thiadiazole-2-thiones
AU1513597A (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
AU6904698A (en) Herbicidal 3,5-difluoropyridines
AU3006797A (en) Substituted 1, 3-benzodioxoles
AU2137095A (en) Heterocyclyl-1,3,4-thiadiazolyloxyacetamides
AU1303897A (en) Herbicidal 1,2,4,6-thiatriazines
AU1375797A (en) Substituted 1,2,4,6-thiatriazines useful as herbicides
HK1018061A (en) Substituted 1,3-benzodioxoles
AU4263999A (en) Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
HK1012395A (en) Biphenylcarboxamides useful as 5-ht1d antagonists